Michael Hallek
Universität zu Köln
H-index: 135
Europe-Germany
Top articles of Michael Hallek
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations | bioRxiv | Alicja Pacholewska Matthias Lienhard Mirko Brueggemann Heike Haenel Lorina Bilalli | 2024 |
Ergebnisse der PET-adaptierten Phase-III-Studie HD21 der deutschen Hodgkin Studiengruppe (GHSG) | Nuklearmedizin-NuclearMedicine | C Kobe M Dietlein G Schneider M Fuchs S Kreissl | 2024/4 |
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL | Cell Reports Medicine | Lars Fabian Prinz Tobias Riet Daniel Felix Neureuther Simon Lennartz Danuta Chrobok | 2024/2/9 |
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the … | Luca Fischer Linmiao Jiang Jan Dürig Christian Schmidt Stephan Stilgenbauer | 2023/12/28 | |
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial | Nature Medicine | Othman Al-Sawaf Rudy Ligtvoet Sandra Robrecht Janina Stumpf Anna-Maria Fink | 2024/1 |
A diagnostic challenge—First case of chronic lymphatic leukemia‐associated necrotizing sweet syndrome | European Journal of Haematology | Marie Anne‐Catherine Neumann Pascal Nieper Florian Simon Alexander Shimabukuro‐Vornhagen Michael Hallek | 2024/4 |
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA | Blood | Jan-Michel Heger Julia Mattlener Jessica Schneider Philipp Gödel Noëlle Sieg | 2024/2/8 |
Acalabrutinib, venetoclax and obinutuzumab in relapsed/refractory CLL: Final efficacy and ctDNA analysis of the CLL2-BAAG trial | Blood | Moritz Fürstenau Adam Giza Jonathan Weiss Fanni Kleinert Sandra Robrecht | 2024/4/16 |
Long‐term remission in a patient with relapsed Richter's transformation treated with CD19‐directed chimeric antigen‐receptor T‐cells after allogeneic stem cell transplantation | European Journal of Haematology | Nadine Kutsch Philipp Gödel Conrad‐Amadeus Voltin Michael Hallek Christof Scheid | 2024/2/5 |
Reassessing the Chronic Lymphocytic Leukemia International Prognostic Index in the era of targeted therapies | Blood | Petra Langerbeins Adam Giza Sandra Robrecht Paula Cramer Julia von Tresckow | 2024/4/16 |
Digital decision support for structural improvement of melanoma tumor boards: using standard cases to optimize workflow | Journal of Cancer Research and Clinical Oncology | David Hoier Carolin Groß-Ophoff-Müller Cindy Franklin Michael Hallek Esther von Stebut | 2024/3/8 |
Post‐transplant‐cyclophosphamide and short‐term Everolimus as graft‐versus‐host‐prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the … | European Journal of Haematology | Tim Richardson Christof Scheid Marco Herling Lukas P Frenzel Carmen Herling | 2024/4/14 |
Hybrid immunity to SARS‐CoV‐2 in patients with chronic lymphocytic leukemia | European Journal of Haematology | Sibylle C Mellinghoff Sandra Robrecht Rosanne Sprute Leonie Mayer Leonie M Weskamm | 2024/2/4 |
253P Digital decision support for structural improvement of lung cancer tumor boards: Using standard cases to optimize workflow | ESMO Open | C Gross-Ophoff-Mueller D Hoier A Oden MJ Hallek A Greeske | 2024/3/1 |
Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del (17p) chronic lymphocytic leukemia | Blood Advances | Stephan Stilgenbauer Eugen Tausch Andrew W Roberts Matthew S Davids Barbara Eichhorst | 2024/2/1 |
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial | Blood | Paula Cramer Julia Von Tresckow Anna-Maria Fink Gracia Braun Sandra Robrecht | 2020/11/5 |
Facing life-threat during youth: a qualitative study on challenges, coping, and needs among adolescents and young adults with cancer | Supportive Care in Cancer | Carolin Wilharm Anne Pralong Mara Weiss Michael Hallek Raymond Voltz | 2024/3 |
Pentose Phosphate Pathway Inhibition activates Macrophages towards phagocytic Lymphoma Cell Clearance | bioRxiv | Anna C Beielstein Elena Izquierdo Stuart J Blakemore Nadine Nickel Michael Michalik | 2023 |
LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1 | Nature Communications | Alexander F Vom Stein Rocio Rebollido-Rios Anna Lukas Maximilian Koch Anton von Lom | 2023/3/10 |
Stromal cells support the survival of human primary chronic lymphocytic leukemia (CLL) cells through Lyn-driven extracellular vesicles | Frontiers in medicine | Thaís de Oliveira Alexander Vom Stein Rocio Rebollido-Rios Liudmila Lobastova Marcus Lettau | 2022 |
Co-Authors
